DJ

Dolly Jaisawal

Active Director Director DIN 08991511
DIN 08991511 First appointment Dec 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2020
Shareholding value •••• Premium profile

About Dolly Jaisawal

Data last updated:

Dolly Jaisawal is a Director at Macarty Pharmaceuticals Private Limited (since 2020). The company operates in Chemicals. Macarty Pharmaceuticals Private Limited reported revenue of ₹2.5 Lakh (FY 2024).

DIN 08991511
Primary Designation Director
Industry Chemicals
First Appointment 14 Dec 2020
Oldest Company Age 8 yrs
Largest company Macarty Pharmaceuticals Private Limited · ₹2.5 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Dec 20202018₹2.5 Lakh (FY 2024)Active

Board colleagues of Dolly Jaisawal

NameDINCompanyDesignation
Anju Jaiswal09631965Macarty Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Macarty Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Dolly Jaisawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dolly Jaisawal

Dolly Jaisawal currently holds 1 directorship: Macarty Pharmaceuticals Private Limited (Director, since 14 Dec 2020, revenue ₹2.5 Lakh (FY 2024)).

Dolly Jaisawal was first appointed on 14 Dec 2020 as Director at Macarty Pharmaceuticals Private Limited.

The current boards of Dolly Jaisawal's companies include Anju Jaiswal (Macarty Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available